Exhaled nitric oxide in seasonal allergic rhinitis: Influence of pollen season and therapy

Clinical and Experimental Allergy

Volumn 31, Issue 3, 2001, Pages 409-416

  Gratziou, C ^a   Rovina, N ^a   Lignos, M ^a   Vogiatzis, I ^a   Roussos, Ch ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Anti inflammatory therapy; Exhaled nitric oxide; Pollen season; Rhinitis

Indexed keywords

BUDESONIDE; FLUTICASONE PROPIONATE; NEDOCROMIL; NITRIC OXIDE; POLLEN ANTIGEN; STEROID;

ADULT; ALLERGIC RHINITIS; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; EXHALATION; EXPIRED AIR; FEMALE; HUMAN; LOWER RESPIRATORY TRACT; MALE; MEASUREMENT; NON INVASIVE MEASUREMENT; POLLEN ALLERGY; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SEASONAL VARIATION; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT;

ADULT; ALLERGENS; ANTI-ALLERGIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEDOCROMIL; NITRIC OXIDE; POLLEN; RHINITIS, ALLERGIC, SEASONAL; STEROIDS;

EID: 0035723557     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01001.x     Document Type: Article

References (29)

1. Epidemiology of seasonal and perennial rhinitis: Clinical presentation and medical history
2. Prevalence of asthma and asthma-like symptoms in three French cities
3. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: Increases in activated eosinophils and epithelial mast cells
4. Cellular inflammation in asthma
5. Cytokine immunoreactivity and seasonal rhinitis: Regulation by a topical corticosteroid
6. Bronchial mucosal manifestations of atopy: A comparison of markers of inflammation between atopic asthmatics, atopic non-asthmatics and healthy controls
7. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperrespnonsiveness and predominant co-localization of eotaxin Mrna to bronchial epithelial and endothelial cells
8. Leucocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis
9. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: Relationship to methacholine responsiveness
10. Asymptomatic bronchial hyperresponsiveness in rhinitis
11. Relationship of upper airways disorders to FEV1 and bronchial hyperresponsiveness in an epidemiological study
12. Nitric oxide and asthmatic inflammation
13. The elevated level of exhaled nitric oxide in asthmatic patients is mainly derived from the lower respiratory tract
14. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections
15. Increased nitric oxide in exhaled air of asthmatic patients
16. Increased amount of nitric oxide in exhaled air of asthmatics
17. Influence of atopy on exhaled nitric oxide in patients with stable asthma
18. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients
19. Induction of nitric oxide synthase in asthma
20. Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis
21. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids
22. Exhaled and nasal NO levels in allergic rhinitis: Relation to sensitization, pollen season and bronchial hyperresponsiveness
23. Exhaled and nasal nitric oxide measurements: Recommendations
24. Allergic rhinitis and asthma: How important is the link?
25. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages
26. Effect of a nitric oxide synthase inhibitor and a glycocorticosteroid on exhaled nitric oxide
27. Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells
28. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients
29. Expired nitric oxide levels during treatment of acute asthma